Cargando…
Gene correction for SCID-X1 in long-term hematopoietic stem cells
Gene correction in human long-term hematopoietic stem cells (LT-HSCs) could be an effective therapy for monogenic diseases of the blood and immune system. Here we describe an approach for X-linked sSevere cCombined iImmunodeficiency (SCID-X1) using targeted integration of a cDNA into the endogenous...
Autores principales: | Pavel-Dinu, Mara, Wiebking, Volker, Dejene, Beruh T., Srifa, Waracharee, Mantri, Sruthi, Nicolas, Carmencita E., Lee, Ciaran, Bao, Gang, Kildebeck, Eric J., Punjya, Niraj, Sindhu, Camille, Inlay, Matthew A., Saxena, Nivedita, DeRavin, Suk See, Malech, Harry, Roncarolo, Maria Grazia, Weinberg, Kenneth I., Porteus, Matthew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456568/ https://www.ncbi.nlm.nih.gov/pubmed/30967552 http://dx.doi.org/10.1038/s41467-019-09614-y |
Ejemplares similares
-
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
por: Pavel-Dinu, Mara, et al.
Publicado: (2019) -
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
por: Pavel-Dinu, Mara, et al.
Publicado: (2019) -
Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
por: Srifa, Waracharee, et al.
Publicado: (2020) -
Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation
por: Wiebking, Volker, et al.
Publicado: (2020) -
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
por: Park, So Hyun, et al.
Publicado: (2019)